Literature DB >> 20140903

Continuous CD27 triggering in vivo strongly reduces NK cell numbers.

Veerle De Colvenaer1, Sylvie Taveirne, Jörg Hamann, Alex M de Bruin, Magda De Smedt, Tom Taghon, Bart Vandekerckhove, Jean Plum, René van Lier, Georges Leclercq.   

Abstract

NK cells are important mediators of the early defense. In mice, immature and mature NK (mNK) cells constitutively express the TNF receptor family member CD27; however, mNK cells eventually lose CD27 expression and become resting NK cells. Interaction of CD27 with its ligand, CD70, enhances proliferation and effector functions of NK cells. We used mice that constitutively express CD70 on B cells (CD70-Tg) to study the in vivo effects of continuous triggering of CD27 on NK cells. Continuous CD70-CD27 interaction resulted in strongly down-modulated CD27 expression on NK cells and gradually reduced absolute NK cell numbers. This reduction was most prominent in the mNK cell subpopulation and was at least partially due to increased apoptosis. Residual NK cells showed lower expression of activating Ly49 receptors and normal (liver) or decreased (spleen) IFN-gamma production. Nevertheless, NK cells from CD70-Tg mice displayed higher YAC-1 killing capacities. CD70-Tg NK cells exhibited up-regulated expression of NKG2D, which is in accordance with the increased YAC-1 lysis, as this is mainly NKG2D-dependent. Taken together, this study is the first to demonstrate that continuous CD70 triggering of CD27 on NK cells in vivo results in a severe reduction of NK cells. On a single cell basis, however, residual NK cells display enhanced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140903     DOI: 10.1002/eji.200939251

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Authors:  Moshe Elkabets; Vera S G Ribeiro; Charles A Dinarello; Suzanne Ostrand-Rosenberg; James P Di Santo; Ron N Apte; Christian A J Vosshenrich
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

2.  Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Authors:  Ren Zhu; Maryline Mancini-Bourgine; Xiao Ming Zhang; Florence Bayard; Qiang Deng; Marie-Louise Michel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

3.  TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.

Authors:  Z-Z Yang; D M Grote; B Xiu; S C Ziesmer; T L Price-Troska; L S Hodge; D M Yates; A J Novak; S M Ansell
Journal:  Leukemia       Date:  2014-02-26       Impact factor: 11.528

4.  Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.

Authors:  Jessica Ann Hernandez-Chacon; Yufeng Li; Richard C Wu; Chantale Bernatchez; Yijun Wang; Jeffrey S Weber; Patrick Hwu; Laszlo G Radvanyi
Journal:  J Immunother       Date:  2011-04       Impact factor: 4.456

5.  CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.

Authors:  Anna Wasiuk; James Testa; Jeff Weidlick; Crystal Sisson; Laura Vitale; Jenifer Widger; Andrea Crocker; Lawrence J Thomas; Joel Goldstein; Henry C Marsh; Tibor Keler; Li-Zhen He
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

6.  IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection.

Authors:  Maria A Stacey; Morgan Marsden; Eddie C Y Wang; Gavin W G Wilkinson; Ian R Humphreys
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

Review 7.  The CD70-CD27 axis in oncology: the new kids on the block.

Authors:  Tal Flieswasser; Astrid Van den Eynde; Jonas Van Audenaerde; Jorrit De Waele; Filip Lardon; Carsten Riether; Hans de Haard; Evelien Smits; Patrick Pauwels; Julie Jacobs
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

8.  Adaptations of Natural Killer Cells to Self-MHC Class I.

Authors:  Stéphanie Bessoles; Camille Grandclément; Elisenda Alari-Pahissa; Jasmine Gehrig; Beena Jeevan-Raj; Werner Held
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

9.  A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.

Authors:  Meinolf Thiemann; David M Richards; Karl Heinonen; Michael Kluge; Viola Marschall; Christian Merz; Mauricio Redondo Müller; Tim Schnyder; Julian P Sefrin; Jaromir Sykora; Harald Fricke; Christian Gieffers; Oliver Hill
Journal:  Front Oncol       Date:  2018-09-19       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.